Cargando…
Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
INTRODUCTION: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet. MATERIALS AND METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618637/ https://www.ncbi.nlm.nih.gov/pubmed/23580937 http://dx.doi.org/10.4103/2230-973X.107005 |
_version_ | 1782265433437503488 |
---|---|
author | Desai, Mayur Jivani, Rishad R Patel, Laxman D Jivani, Noordin P Sonagara, Bhavin |
author_facet | Desai, Mayur Jivani, Rishad R Patel, Laxman D Jivani, Noordin P Sonagara, Bhavin |
author_sort | Desai, Mayur |
collection | PubMed |
description | INTRODUCTION: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet. MATERIALS AND METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. RESULT: The lag time of the drug release decreased by increasing the inner swelling layer and increased by increasing the rupturing layer level. CONCLUSION: The results obtain from present study suggest that swelling come reputable coating approach gives desire drug release after lag time. |
format | Online Article Text |
id | pubmed-3618637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36186372013-04-11 Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release Desai, Mayur Jivani, Rishad R Patel, Laxman D Jivani, Noordin P Sonagara, Bhavin Int J Pharm Investig Original Research Article INTRODUCTION: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet. MATERIALS AND METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. RESULT: The lag time of the drug release decreased by increasing the inner swelling layer and increased by increasing the rupturing layer level. CONCLUSION: The results obtain from present study suggest that swelling come reputable coating approach gives desire drug release after lag time. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3618637/ /pubmed/23580937 http://dx.doi.org/10.4103/2230-973X.107005 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Desai, Mayur Jivani, Rishad R Patel, Laxman D Jivani, Noordin P Sonagara, Bhavin Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release |
title | Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release |
title_full | Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release |
title_fullStr | Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release |
title_full_unstemmed | Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release |
title_short | Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release |
title_sort | development of time controlled chronomodulated tablet with swelling and rupturable layers: optimization of factors influencing lag-time and drug release |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618637/ https://www.ncbi.nlm.nih.gov/pubmed/23580937 http://dx.doi.org/10.4103/2230-973X.107005 |
work_keys_str_mv | AT desaimayur developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease AT jivanirishadr developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease AT patellaxmand developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease AT jivaninoordinp developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease AT sonagarabhavin developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease |